The Department of Health, Disability and Ageing and the Pharmaceutical Benefits Advisory Committee (PBAC) have established an ongoing process for maintaining and improving the PBAC Guidelines, as outlined in the rolling review of PBAC Guidelines document, ensuring they remain current, clear and fit-for-purpose, while preserving existing governance and decision-making arrangements.
The Department has also published a document on the use of artificial intelligence (AI) in PBAC submissions and evaluations. The document outlines the PBAC’s expectations for the responsible use of AI in health technology assessment processes, including transparency, accountability and appropriate human oversight. It aims to support confidence in the evidence considered by the PBAC while enabling the appropriate use of emerging technologies.